1 |
Gross G, Schöfer H, Wassilew S, Friese K, Timm A, Guthoff R, et al: Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol 2003; 26: 277-89
DOI
ScienceOn
|
2 |
Galluzzi KE: Management strategies for herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc 2007; 107 (Suppl 1): 8-13
|
3 |
Wassilew S: Collaborative Brivudin PHN study group. Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients: a randomized, double-blind, multinational study. J Eur Acad Dermatol Venereol 2005; 19: 47-55
DOI
ScienceOn
|
4 |
Dworkin RH, Schmader KE: Treatment and prevention of postherpetic neuralgia. Clin Infect Dis 2003; 36: 877-82
DOI
ScienceOn
|
5 |
Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, et al: Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003; 60: 1524-34
DOI
ScienceOn
|
6 |
Eisenberg E, McNicol ED, Carr DB: Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 2005; 293: 3043-52
DOI
ScienceOn
|
7 |
Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al: A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-84
DOI
ScienceOn
|
8 |
Volpi A: Severe complications of herpes zoster. Herpes 2007; 14(Suppl 2): 35-9
|
9 |
Walton RC, Reed KL: Herpes zoster ophthalmicus following bone marrow transplantation in children. Bone Marrow Transplant 1999; 23: 1317-20
DOI
|
10 |
Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL: Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352: 1324-34
DOI
ScienceOn
|
11 |
Hardy D: Relief of pain in acute herpes zoster by nerve blocks and possible prevention of post-herpetic neuralgia. Can J Anaesth 2005; 52: 186-90
DOI
|
12 |
Murakami S, Hato N, Horiuchi J, Honda N, Gyo K, Yanagihara N: Treatment of Ramsay Hunt syndrome with acyclovir- prednisone: significance of early diagnosis and treatment. Ann Neurol 1997; 41: 353-7
DOI
ScienceOn
|
13 |
Pasqualucci A, Pasqualucci V, Galla F, De Angelis V, Marzocchi V, Colussi R, et al: Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand 2000; 44: 910-8
DOI
ScienceOn
|
14 |
Dureja GP, Bhalla AP: Multimodality regimen for the management of postherpetic neuralgia. Pain Clin 1991; 5: 15-9
|
15 |
Rowbotham MC, Young JP Jr, Sharma U: Pregabalin significantly reduces neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia by day 3 of treatment. In: Program and abstracts of neuropathic pain: changing paradigms in diagnosis and treatment. Edited by International Association for the Study of Pain Neuropathic Pain Special Interest Group: Seattle, IASP Press. 2004, p 48
|
16 |
Harding SP: Management of ophthalmic zoster. J Med Virol 1993; 40(Suppl 1): 97-101
|
17 |
Higa K, Hori K, Harasawa I, Hirata K, Dan K: High thoracic epidural block relieves acute herpetic pain involving the trigeminal and cervical regions: comparison with effects of stellate ganglion block. Reg Anesth Pain Med 1998; 23: 25-9
|
18 |
Watson CP: A new treatment for postherpetic neuralgia. N Engl J Med 2000; 343: 1563-5
DOI
ScienceOn
|
19 |
Dworkin RH, Corbin AE, Young JP Jr, Sharma U, LaMoreaux L, Bockbrader H, et al: Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebocontrolled trial. Neurology 2003; 60: 1274-83
DOI
ScienceOn
|
20 |
Dworkin RH, Schmader KE: The epidemiology and natural history of herpes zoster and postherpetic neuralgia. In:Herpes zoster and postherpetic neuralgia. 2nd ed. Edited by Watson CPN, Gershon AA: New York, Elsevier Press. 2001, pp 39-64
|
21 |
Rowbotham MC, Reisner LA, Davies PS, Fields HL: Treatment response in antidepressant-naive postherpetic neuralgia patients: double-blind, randomized trial. J Pain 2005; 6: 741-6
DOI
ScienceOn
|
22 |
Volmink J, Lancaster T, Gray S, Silagy C: Treatments for postherpetic neuralgia--a systematic review of randomized controlled trials. Fam Pract 1996; 13: 84-91
DOI
ScienceOn
|
23 |
Wu CL, Raja SN: An update on the treatment of postherpetic neuralgia. J Pain 2008; 9(Suppl 1): 19-30
|
24 |
Watson CP, Babul N: Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998; 50: 1837-41
DOI
ScienceOn
|
25 |
Berry JD, Petersen KL: A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster. Neurology 2005; 65: 444-7
DOI
|
26 |
Gnann JW Jr: Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 2002; 186(Suppl 1): 91-8
DOI
ScienceOn
|
27 |
Manabe H, Dan K, Higa K: Continuous epidural infusion of local anesthetics and shorter duration of acute zoster-associated pain. Clin J Pain 1995; 11: 220-8
DOI
ScienceOn
|
28 |
Dunteman E: Peripheral nerve stimulation for unremitting ophthalmic postherpetic neuralgia. Neuromodulation 2002; 5: 32-7
DOI
ScienceOn
|
29 |
Schmader K, George LK, Burchett BM, Pieper CF, Hamilton JD: Racial differences in the occurrence of herpes zoster. J Infect Dis 1995; 171: 701-4
DOI
ScienceOn
|
30 |
Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC:The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 2002; 18: 297-301
DOI
ScienceOn
|
31 |
Mao J, Chen LL: Systemic lidocaine for neuropathic pain relief. Pain 2000; 87: 7-17
DOI
ScienceOn
|
32 |
Kochar DK, Garg P, Bumb RA, Kochar SK, Mehta RD, Beniwal R, et al: Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebocontrolled study. QJM 2005; 98: 29-34
DOI
ScienceOn
|
33 |
Kuraishi Y, Takasaki I, Nojima H, Shiraki K, Takahata H: Effects of the suppression of acute herpetic pain by gabapentin and amitriptyline on the incidence of delayed postherpetic pain in mice. Life Sci 2004; 74: 2619-26
DOI
ScienceOn
|
34 |
Bowsher D: The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain 1999; 3: 335-42
DOI
ScienceOn
|
35 |
Hwang SM, Kang YC, Lee YB, Yoon KB, Ahn SK, Choi EH: The effects of epidural blockade on the acute pain in herpes zoster. Arch Dermatol 1999; 135: 1359-64
DOI
|
36 |
Ray WA, Meredith S, Thapa PB, Hall K, Murray KT: Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004; 75: 234-41
DOI
ScienceOn
|
37 |
Lipton JR, Harding SP, Wells JC: The effect of early stellate ganglion block on postherpetic neuralgia in herpes zoster ophthalmicus. Pain Clin 1987; 1: 247-51
|
38 |
Winnie AP, Hartwell PW: Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth 1993; 18: 277-82
|
39 |
Balfour HH Jr, Bean B, Laskin OL, Ambinder RF, Meyers JD, Wade JC, et al: Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med 1983; 308: 1448-53
DOI
ScienceOn
|
40 |
Manfredi PL: Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003; 60: 1052-3
|
41 |
Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al: Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007; 132: 237-51
DOI
ScienceOn
|
42 |
Shaikh S, Ta CN: Evaluation and management of herpes zoster ophthalmicus. Am Fam Physician 2002; 66: 1723-30
|
43 |
De Diego JI, Prim MP, De Sarriá MJ, Madero R, Gavilán J: Idiopathic facial paralysis: a randomized, prospective, and controlled study using single-dose prednisone versus acyclovir three times daily. Laryngoscope 1998; 108: 573-5
DOI
ScienceOn
|
44 |
Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH: Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118: 289-305
DOI
ScienceOn
|
45 |
Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L: Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280: 1837-42
DOI
ScienceOn
|
46 |
Dick IE, Brochu RM, Purohit Y, Kaczorowski GJ, Martin WJ, Priest BT: Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. J Pain 2007; 8: 315-24
DOI
ScienceOn
|
47 |
Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, et al: Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Collaborative famciclovir herpes zoster study group. Ann Intern Med 1995; 123: 89-96
DOI
ScienceOn
|
48 |
Johnson RW: Zoster-associated pain: what is known, who is at risk and how can it be managed? Herpes 2007; 14(Suppl 2): 30-4
|
49 |
Haanpaa M, Laippala P, Nurmikko T: Allodynia and pinprick hypesthesia in acute herpes zoster, and the development of postherpetic neuralgia. J Pain Symptom Manage 2000; 20: 50-8
DOI
ScienceOn
|
50 |
Boureau F, Legallicier P, Kabir-Ahmadi M: Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebocontrolled trial. Pain 2003; 104: 323-31
DOI
ScienceOn
|
51 |
Rice AS, Maton S; Postherpetic Neuralgia Study Group: Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 2001; 94: 215-24
DOI
ScienceOn
|
52 |
Gnann JW Jr, Crumpacker CS, Lalezari JP, Smith JA, Tyring SK, Baum KF, et al: Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative antiviral study group/aids clinical trials group, herpes zoster study group. Antimicrob Agents Chemother 1998; 42: 1139-45
|
53 |
Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR: Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain 1999; 81: 135-45
DOI
ScienceOn
|
54 |
Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ: Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 2000; 9: 863-9
DOI
ScienceOn
|
55 |
Decroix J, Partsch H, Gonzalez R, Mobacken H, Goh CL, Walsh L, et al: Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. Valaciclovir International Zoster Assessment Group (VIZA). J Eur Acad Dermatol Venereol 2000; 14: 23-33
DOI
ScienceOn
|
56 |
Wasner G, Kleinert A, Binder A, Schattschneider J, Baron R: Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin. J Neurol 2005; 252: 677-86
DOI
|
57 |
Gilbert SC: Bell's palsy and herpes viruses. Herpes 2002; 9: 70-3
|
58 |
Zaal MJ, Volker-Dieben HJ, D'Amaro J: Prognostic value of Hutchinson's sign in acute herpes zoster ophthalmicus. Graefes Arch Clin Exp Ophthalmol 2003; 241: 187-91
DOI
|
59 |
Kikuchi A, Kotani N, Sato T, Takamura K, Sakai I, Matsuki A: Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 1999; 24: 287-93
|
60 |
Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS: Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2005; 2: e164
DOI
ScienceOn
|
61 |
Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ: Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004; 328: 991
DOI
ScienceOn
|
62 |
Jung BF, Johnson RW, Griffin DR, Dworkin RH: Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62: 1545-51
DOI
ScienceOn
|
63 |
Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ: Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995; 39: 1546-53
DOI
ScienceOn
|
64 |
Wutzler P, De Clercq E, Wutke K, Färber I: Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized doubleblind trial. J Med Virol 1995; 46: 252-7
DOI
ScienceOn
|
65 |
Pavan-Langston D: Viral disease of the ocular anterior segment: basic science and clinical disease. In: The cornea. 4th ed. Edited by Foster S, Azar D, Dohlman C: Philadelphia, Lippincott Williams & Wilkins. 2005, pp 297-397
|
66 |
Kim JO, Lee MK, Kim JS, Kim DJ: Spinal cord stimulation for intractable postherpetic neuralgia. J Korean Neurosurg Soc 2003; 34: 366-8
|
67 |
Kashiwase M, Sata T, Yamauchi Y, Minoda H, Usui N, Iwasaki T, et al: Progressive outer retinal necrosis caused by herpes simplex virus type 1 in a patient with acquired immunodeficiency syndrome. Ophthalmology 2000; 107: 790-4
DOI
ScienceOn
|
68 |
Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al: Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44(Suppl 1): 1-26
DOI
|
69 |
Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG, et al: Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebocontrolled trial. The national institute of allergy and infectious diseases collaborative antiviral study group. Ann Intern Med 1996; 125: 376-83
DOI
ScienceOn
|